ISIN | LU2023372795 |
---|---|
Valor Number | 48765109 |
Bloomberg Global ID | CSEEBDE LX |
Fund Name | UBS (Lux) Fund Solutions II - UBS MSCI Europe Selection Index Fund EUR I-B acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | Equity Advanced Europe |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The Subfund tracks the MSCI Europe Selection Index as its benchmark index. The Investment Objective of the Subfund is to provide the Shareholders with a return in line with the performance of the MSCI Europe Selection Index (the “Underlying Index”). |
Peculiarities |
Current Price * | 1,496.73 EUR | 02.07.2025 |
---|---|---|
Previous Price * | 1,494.29 EUR | 01.07.2025 |
52 Week High * | 1,548.20 EUR | 26.02.2025 |
52 Week Low * | 1,297.42 EUR | 09.04.2025 |
NAV * | 1,496.73 EUR | 02.07.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 152,567,642 | |
Unit/Share Assets *** | 19,585,454 | |
Trading Information SIX |
YTD Performance | +4.69% |
31.12.2024 - 02.07.2025
31.12.2024 02.07.2025 |
---|---|---|
YTD Performance (in CHF) | +4.01% |
31.12.2024 - 02.07.2025
31.12.2024 02.07.2025 |
1 month | -1.02% |
02.06.2025 - 02.07.2025
02.06.2025 02.07.2025 |
3 months | +1.61% |
02.04.2025 - 02.07.2025
02.04.2025 02.07.2025 |
6 months | +4.00% |
02.01.2025 - 02.07.2025
02.01.2025 02.07.2025 |
1 year | +0.32% |
02.07.2024 - 02.07.2025
02.07.2024 02.07.2025 |
2 years | +16.85% |
03.07.2023 - 02.07.2025
03.07.2023 02.07.2025 |
3 years | +34.91% |
04.07.2022 - 02.07.2025
04.07.2022 02.07.2025 |
5 years | +56.08% |
02.07.2020 - 02.07.2025
02.07.2020 02.07.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
ASML Holding NV | 4.43% | |
---|---|---|
Novartis AG Registered Shares | 3.83% | |
AstraZeneca PLC | 3.77% | |
Novo Nordisk AS Class B | 3.64% | |
HSBC Holdings PLC | 3.38% | |
Unilever PLC | 2.68% | |
Lvmh Moet Hennessy Louis Vuitton SE | 2.58% | |
Schneider Electric SE | 2.15% | |
TotalEnergies SE | 2.12% | |
L'Oreal SA | 1.79% | |
Last data update | 30.04.2025 |
TER | 0.05% |
---|---|
TER date | 31.12.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.05% |
Ongoing Charges *** | 0.05% |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |